Oct 2026· Journal of Thoracic and Cardiovascular Surgery· 0 citations
Medicine
TL;DR
Requiring limited data entry and employing novel statistical methodology, AQG provided predictions similar to those of STS-ACSD, both confirming and augmenting understanding of the volume-outcome relationship in surgical management of posterior mitral valve prolapse.
Abstract
Objective
In patients undergoing surgical repair of posterior mitral valve prolapse, we compared outcomes in high- and low-volume mitral surgery hospitals to those predicted by the AATS Adult Quality Gateway (AQG) and the Society of Thoracic Surgeons Adult Cardiac Surgery Database (STS-ACSD).
Methods
Five hospitals performed 1,517 mitral valve operations, 1,471 repairs (97%) and 46 replacements (3.0%), in the AQG training set of 55,246 adult patients. Mitral repair techniques included leaflet resection (80%), creating artificial chordae (20%), and anuloplasty (99%); surgical approach was sternotomy or partial sternotomy in 945 (64%) and anterior thoracotomy or robotic in 525 (36%). The remaining 14 hospitals performed 159 mitral valve operations, 145 repairs (91%) and 14 (8.8%) replacements.
Results
In high-volume hospitals, predicted mortality by AQG was 0.87% and by STS-ACSD 0.77%; however, observed mortality was 1 patient (0.070%). For major morbidity and mortality, AQG predicted 8.1% and STS-ACSD 6.5%, but observed was 4.0%. Patients undergoing valve replacement were more likely to be older and more symptomatic and had more tricuspid regurgitation and mitral anular calcification. All repair outcomes were worse (e.g., operative mortality was 3/145 [2.1%]) in low-volume hospitals.
Conclusions
Requiring limited data entry and employing novel statistical methodology (e.g. virtual twins), AQG provided predictions similar to those of STS-ACSD, both confirming and augmenting understanding of the volume-outcome relationship in surgical management of posterior mitral valve prolapse.
Despite a higher comorbidity burden and residual baseline imbalance after matching, early and mid-term outcomes were acceptable and totally endoscopic chordal-sparing MV replacement represents a safe and clinically effective treatment option for selected patients.
F. Sobik, J. Pausch, Xiao-Qin Hua et al.· Frontiers in Cardiovascular...· 0 citations
In carefully selected high-risk patients with recurrent or persistent mitral valve disease, Tendyne TMVI achieved durable prosthetic mitral valve function, leading to significant symptomatic improvement.
C. Wahl, S. Voss, M. Erlebach et al.· International Journal of Car...· 0 citations
Background
Paravalvular leak involving a prosthetic mitral valve (M-PVL) is a rare but serious complication after mitral valve replacement (MVR). This study evaluated contemporary outcomes after surgical correction of M-PVL and investigated factors associated with its recurrence.
Methods
This retrospective study incl...
Han Cho, J. Choi, K. H. Kim et al.· Journal of chest surgery· 0 citations
Background Obesity may increase the technical complexity of robotic mitral valve (MV) repair, but comparative outcomes with sternotomy remain poorly defined. Objectives This study aimed to compare perioperative and long-term outcomes of robotic vs sternotomy MV repair in patients with class I obesity. Methods A total o...
Sina Danesh, H. Schaff, Aurora D. Lee et al.· JACC: Advances· 0 citations
The combination of RDV and a minimally invasive approach proved to be safe, with low morbidity and mortality and excellent short-term hemodynamic improvement.
Tomás D'Angelo, Germán A. Fortunato, Martín Chrabalowski et al.· Revista Argentina de Cardiol...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.